Dmitrii Y Travin

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 5

Top Topics

Staphylococcus Aureus

Dna Methylation

Anterior Cruciate Ligament Reconstruction

Top Venues

RSC chemical biology

Microbiology resource announcements

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Dmitrii Y Travin, Romain Jouan, Armelle Vigouroux, Satomi Inaba-Inoue, Joy Lachat, Fazal Haq, Tatiana Timchenko, Dmitry Sutormin, Svetlana Dubiley, Konstantinos Beis, Solange Moréra, Konstantin Severinov, Peter Mergaert
Dual-Uptake Mode of the Antibiotic Phazolicin Prevents Resistance Acquisition by Gram-Negative Bacteria. mBio (2023)
Dmitrii Y Travin, Dmitry Sutormin, Peter Mergaert, Konstantin Severinov
Complete Genome Sequences of Two Rhizobium Strains Producing Azol(in)e-Modified Antibiotics. Microbiology resource announcements 11 (11) (2022)
Dmitrii Y Travin, Konstantin Severinov, Svetlana Dubiley
Natural Trojan horse inhibitors of aminoacyl-tRNA synthetases. RSC chemical biology 2 (2) (2021)
Dmitrii Y Travin, Zoe L Watson, Mikhail Metelev, Fred R Ward, Ilya A Osterman, Irina M Khven, Nelli F Khabibullina, Marina V Serebryakova, Peter Mergaert, Yury S Polikanov, Jamie H D Cate, Konstantin Severinov
Structure of ribosome-bound azole-modified peptide phazolicin rationalizes its species-specific mode of bacterial translation inhibition. Nature communications 10 (1) (2019)
Dmitrii Y Travin, Mikhail Metelev, Marina Serebryakova, Ekaterina S Komarova, Ilya A Osterman, Dmitry Ghilarov, Konstantin Severinov
Biosynthesis of Translation Inhibitor Klebsazolicin Proceeds through Heterocyclization and N-Terminal Amidine Formation Catalyzed by a Single YcaO Enzyme. Journal of the American Chemical Society 140 (16) (2018)